Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration New agreements expand and extend November 2007 antibody collaboration Collaboration goal is to advance 4 to 5 antibodies per year into clinical development Sanofi-aventis to fund up to $160M annually for Regeneron antibody
Thursday, November 12, 2009 1 min read
Key Takeaway: Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration New agreements expand and extend November 2007 antibody collaboration Collaboration goal is to advance 4 to 5 antibodies per year into clinical development Sanofi-aventis to fund up to $160M annually for Regeneron antibody
Full Press Release Details
Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration New agreements expand and extend November 2007 antibody collaboration Collaboration goal is to advance 4 to 5 antibodies per year into clinical development Sanofi-aventis to fund up to $160M annually for Regeneron antibody.